KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CRISPR Therapeutics AG (CRSP) Interest & Investment Income (2016)

CRISPR Therapeutics AG's Interest & Investment Income history spans 2 years, with the latest figure at $1000.0 for Q4 2016.

  • For Q4 2016, Interest & Investment Income changed N/A year-over-year to $1000.0; the TTM value through Dec 2016 reached -$8.0 million, changed N/A, while the annual FY2016 figure was -$8.0 million, 7353.7% down from the prior year.
  • Interest & Investment Income for Q4 2016 was $1000.0 at CRISPR Therapeutics AG, up from -$1000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1000.0 in Q4 2016 and bottomed at -$8.0 million in Q1 2016.